John previously served as CEO of Torque Therapeutics, which combined with Cogen Immune Medicine to form Repertoire. Prior to that, Mr. Cox served as CEO of Bioverativ, leading its spin-out from Biogen in 2016 through its acquisition by Sanofi in 2018. Previously, he held several senior executive positions at Biogen from 2003 to 2016, most recent...
Roles at Repertoire Immune Medicines
Anthony CoylePresident, Research and Development
Sok Cheng SohChief Financial Officer
Jan KisielowChief Scientific Officer, Repertoire Immune Medicines (Switzerland) Ltd.